4/11/2008

Cedars-Sinai Medical Center, which is taking part in a new PET contrast agent clinical trial, is also focusing on how PET can be more widely used in nuclear cardiology. "PET cameras have developed better resolution and higher sensitivity, which affords us the potential to measure absolute myocardial blood flow at rest and at stress in a way that, to date, had not been possible with SPECT," said Cedars-Sinai's director of nuclear cardiology and cardiac imaging.

Related Summaries